NEOGENOMICS INC's ticker is and the CUSIP is 64049MAA8. A total of 13 filers reported holding NEOGENOMICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $3,213 | -8.8% | 3,464,000 | -8.8% | 0.00% | -20.0% |
Q3 2023 | $3,524 | -0.2% | 3,799,000 | 0.0% | 0.01% | 0.0% |
Q2 2023 | $3,531 | +0.1% | 3,799,000 | 0.0% | 0.01% | 0.0% |
Q1 2023 | $3,526 | +24.9% | 3,799,000 | +12.8% | 0.01% | +25.0% |
Q4 2022 | $2,822 | -99.9% | 3,367,000 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $2,909,000 | -4.8% | 3,367,000 | -8.6% | 0.00% | 0.0% |
Q2 2022 | $3,056,000 | -2.6% | 3,682,000 | 0.0% | 0.00% | +33.3% |
Q1 2022 | $3,139,000 | – | 3,682,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TENOR CAPITAL MANAGEMENT Co., L.P. | 42,653,000 | $41,567,428 | 0.65% |
LINDEN ADVISORS LP | 49,111,000 | $47,690,263 | 0.40% |
CAPSTONE INVESTMENT ADVISORS, LLC | 40,019,000 | $39,043,537 | 0.12% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,500,000 | $6,305,559 | 0.10% |
LAZARD ASSET MANAGEMENT LLC | 29,758,000 | $29,032 | 0.04% |
JPMORGAN CHASE & CO | 395,000 | $383,348 | 0.00% |
DEUTSCHE BANK AG\ | 36,000 | $34,762 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Amundi | 255,000 | $246,075 | 0.00% |
BANK OF AMERICA CORP /DE/ | 1,267,000 | $1,223,453 | 0.00% |